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Target-derived factors organize synaptogene-
sis by promoting differentiation of nerve termi-
nals at synaptic sites. Several candidate orga-
nizing molecules have been identified based
on their bioactivities in vitro, but little is known
about their roles in vivo. Here, we show that
three sets of organizers act sequentially to pat-
tern motor nerve terminals: FGFs, b2 laminins,
and collagen a(IV) chains. FGFs of the 7/10/22
subfamily and broadly distributed collagen IV
chains (a1/2) promote clustering of synaptic
vesicles as nerve terminals form. b2 laminins
concentrated at synaptic sites are dispensable
for embryonic development of nerve terminals
but are required for their postnatal maturation.
Synapse-specific collagen IV chains (a3–6) ac-
cumulate only after synapses are mature and
are required for synaptic maintenance. Thus,
multiple target-derived signals permit discrete
control of the formation, maturation, and main-
tenance of presynaptic specializations.
INTRODUCTION
Synapses, which mediate information processing in the
nervous system, form at points of contact between axons
and their targets. Several features of synapses suggest
that their formation is organized by the exchange of devel-opmentally relevant signals between the synaptic part-
ners. For example, pre- and postsynaptic specializations
are precisely apposed to each other; pre- and postsynap-
tic differentiation are temporally as well as spatially coor-
dinated; and the chemical and physiological features of in-
dividual synapses (such as the neurotransmitter released
by the presynaptic cell and the receptor clustered in the
postsynaptic membrane) are matched. Moreover, synap-
tic specializations often fail to form or mature when axons
are experimentally prevented from contacting their tar-
gets; in contrast, generation of novel juxtapositions be-
tween neurites leads to formation of synapses at points
of ectopic contact (Sanes and Lichtman, 1999; Fox and
Umemori, 2006).
Based on these observations, many groups have
sought synaptic organizing molecules, generally using
cultured neurons to assay bioactivity. Over the past
decade, several have been identified. Focusing on mole-
cules that promote presynaptic differentiation, these in-
clude the membrane-associated adhesion and signaling
molecules neuroligin, SynCAM, and Eph kinases; the ex-
tracellular matrix components thrombospondin and lami-
nin b2; members of the Wnt and fibroblast growth factor
(FGF) families of secreted differentiation factors; and cho-
lesterol (Noakes et al., 1995; Biederer et al., 2002; Dean
et al., 2003; Umemori et al., 2004; Christopherson et al.,
2005; Goritz et al., 2005; Ahmad-Annuar et al., 2006; re-
viewed in Ziv and Garner, 2004; Craig et al., 2006; Fox
and Umemori, 2006).
This embarrassment of riches leads to a new question:
Do organizers with similar effects in vitro play distinct roles
in vivo? One possibility is that different synapses useCell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc. 179
different organizers in vivo even though each is capable of
affecting a variety of neuronal types in vitro. Second, dif-
ferent organizers might promote distinct aspects of differ-
entiation such as recruitment of ion channels or clustering
of synaptic vesicles. Third, multiple organizers could act
combinatorially, allowing fine control of synaptogenesis.
Fourth, organizers may act sequentially, with different
molecules regulating the initial development, subsequent
maturation, and dynamic maintenance of the synapse.
Fifth, some factors capable of promoting presynaptic dif-
ferentiation in culture may have different functions in vivo,
such as regulation of synaptic efficacy. Clearly, many
other possibilities exist.
Here, we use the mouse neuromuscular junction (NMJ)
to address this issue. This synapse is large and experi-
mentally accessible, and its development has been ana-
lyzed in detail (Sanes and Lichtman, 1999; Kummer
et al., 2006). Using targeted mouse mutants, we show
that members of three gene families (FGF, laminin, and
collagen IV) all play roles at the NMJ. Although their effects
on cultured motoneurons are superficially similar, they
have distinct and sequential effects in vivo: FGFs and
collagen a1/2(IV) chains direct the initial differentiation of
nerve terminals, b2 laminins promote their maturation,
and collagen a3–6(IV) chains are required to maintain
them. Thus, one rationale for the existence of multiple or-
ganizers is to permit separate control of distinct phases in
the life of a synapse. Finally, we provide evidence that
developmental regulation of the organizers’ expression
accounts at least in part for the timing of their effects.
RESULTS
FGF-Dependent Presynaptic Differentiation
in Nerve-Muscle Cocultures
A critical step in presynaptic differentiation is the cluster-
ing of synaptic vesicles within varicosities. We found
recently that three closely related members of the FGF
family, FGF7, -10, and -22, promote vesicle clustering in
several neuronal types in vitro and in pontine and in vestib-
ular axons in vivo (Umemori et al., 2004). To begin the
present study, we asked whether FGFs also mediate for-
mation of synaptic varicosities at NMJs formed in vitro be-
tween embryonic spinal motoneurons and cells of the C2
myogenic line. RT-PCR showed that C2 cells cultured
alone expressed FGF7, -10, and -22 (Figure 1A). FGF7,
-10, and -22 signal through an alternatively spliced form
of FGF receptor 2 (FGFR2) called FGFR2b; they activate
the FGFR2c isoform poorly if at all (Zhang et al., 2006).
Motoneurons cultured alone expressed both FGFR2b
and FGFR2c, whereas muscle cells expressed FGFR2c
but not FGFR2b (Figures 1A–1C). When the two cell types
were cocultured, motoneurons extended neurites that
contacted C2 myotubes and formed synaptic vesicle-
rich varicosities at these sites (Figure 1D). To ask whether
FGF7/10/22 are presynaptic organizers in this system, we
generated soluble proteins in which the extracellular do-
mains of FGFR2b or FGFR2c were fused to alkaline180 Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc.Figure 1. FGF-Dependent Presynaptic Differentiation in
Cultured Motoneurons
(A) RT-PCR analysis shows that FGF7, FGF10, FGF22, and FGFR2c
are all expressed by both C2 myoblasts (mb) and myotubes (mt).
FGFR2b is not expressed by either myoblasts or myotubes. Glyceral-
dehyde 3-phosphate dehydrogenase (G3PDH) was used as a control.
(B) RT-PCR analysis shows that FGFR2b and -2c are both expressed
by isolated embryonic motoneurons.
(C) FGFR2 is present on motoneuron neurites. Cultured motoneurons
were stained for FGFR2 and either acetylated tubulin or the synaptic
vesicle protein SV2.
(D) Motoneurons and myotubes were cocultured for 3 days with
FGFR2bAP, FGFR2cAP, or control protein (AP) then stained for synap-
sin. FGFR2bAP, which sequesters FGF7, -10, and -22, but not
FGFR2cAP, prevents formation of vesicle-rich varicosities at sites of
neurite-myotube contact. Dotted lines indicate the edges ofmyotubes.
Arrowheads indicate all varicosities on a single neurite in the field of
view.
(E) Quantitation of results from cocultures such as those in (D). Bars
showmean ±SEM for 100 neurites per condition. *: differs from control
and from FGFR2cAP at p < 0.01 by Tukey test. Var indicates vesicle-
rich varicosities.
Bar is 75 mm in (C) and (D).
phosphatase (AP). FGFR2bAP binds to and thereby neu-
tralizes FGF7/10/22, while FGFR2cAP serves as a control
(Ornitz et al., 1992; Umemori et al., 2004). Neither protein
had any detectable effect on neurite elongation (control:
470 ± 21 mm; FGFR2bAP: 449 ± 19 mm; FGFR2cAP:
453 ± 52 mm; mean ± SEM, n = 21) or myotube differenti-
ation (data not shown). However, FGFR2bAP reduced
the incidence of varicosities at neurite-myotube contacts
by >80% (Figures 1D and 1E). These results suggest
that FGFs of the 7/10/22 subfamily are target derived
mediators of presynaptic differentiation at the NMJ.
FGF-Dependent Presynaptic Differentiation
at Embryonic NMJs
In vivo as in vitro, developing motoneurons express
FGFR2, and muscles express all three members of the
FGF7/10/22 subfamily (Figures 2H and 2I). Because all of
these FGFs might act as target-derived organizers, we
tested their role by using an isoform-specific targeted mu-
tant that selectively inactivates FGFR2b without detect-
ably affecting expression of FGFR2c (Eswarakumar
et al., 2002; Figure 2A). Synaptic vesicles were stained
with antibodies to synaptophysin, synaptotagmin, or
synapsin; axons were stained with antibodies to neuro-
filaments; and acetylcholine receptor (AChR)-rich post-
synaptic sites on myotubes were stained with a-bungaro-
toxin (BTX).
In wild-type mice, synaptic vesicles are initially present
throughout the motor axon but become progressively
concentrated at synaptic sites as terminals form in appo-
sition to AChR clusters (Lupa et al., 1990). In FGFR2b/
mice, axons entered muscles normally and arborized at
AChR-rich sites. Moreover, numerous vesicles were pres-
ent in motor axons of these mutants (Figures 2C–2E and
S1). By E16, however, vesicles were less restricted to
synaptic sites in FGFR2b/ muscles than in controls
(Figures 2B and S1). The increased density of vesicles
in mutants was striking in distal nerve branches near syn-
aptic sites but minimal in proximal regions and in main
nerve trunks (Figure 2C). Western blotting demonstrated
similar levels of synapsin in diaphragms and phrenic
nerves of E18 mutants and littermate controls (data
not shown). These results suggest that FGF signaling
through FGFR2b is dispensable for vesicle formation
and transport but is required for their local accumulation
in nerve terminals.
FGFR2b/mutants die at birth due to lung defects (De
Moerlooze et al., 2000), so we were unable to assess the
effect of FGF7/10/22 signaling postnatally. To circumvent
this limitation, we used a conditional FGFR allele
(FGFR2flox) in which all isoforms of FGFR2 can be deleted
from specific cell types by Cre-mediated excision (Yu
et al., 2003). Here, we used mice that expressed Cre
recombinase under the control of regulatory elements
from the HB9 or Islet 1 (Isl) genes, which restrict expres-
sion of Cre to a small subset of cell types including moto-
neurons (Figure 2F). We verified motoneuronal expression
of Cre in these mice by mating them to mice that expressYFP in neurons following Cre-mediated excision of the
stop cassette (Buffelli et al., 2003; data not shown).
FGFR2flox/flox; HB9-Cre and FGFR2flox/flox; Isl-Cre mice
were born in expected numbers. They were smaller than
littermate controls and exhibited a mild tremor but other-
wise were outwardly normal. At embryonic stages, the
neuromuscular phenotypes of FGFR2flox/flox; HB9-Cre
and FGFR2flox/flox; Isl-Cre mice were indistinguishable
from those described above for FGFR2b/ mice: NMJs
formed on schedule, but vesicles were less concentrated
at synaptic sites in mutants than in controls (Figures 2G
andS2). A similar defect was observed inmutant neonates
and during the first postnatal week (extrasynaptic/synap-
tic ratio, calculated as in Figure 2B, 0.44 ± 0.02, n = 45 for
control and 0.60 ± 0.03, n = 60 for mutants at P0; mean ±
SEM; p < 0.0001). Remarkably, however, the abnormality
was transient: it was less striking by P7 than at birth and
barely detectable during the third postnatal week (extrasy-
naptic/synaptic ratio, 0.31 ± 0.02 for control and 0.36 ±
0.07 for mutants at P17; Figures 2G and S2). Thus, FGF
signaling is required for clustering of synaptic vesicles in
embryos, but other mechanisms can eventually promote
clustering independent of FGFR2.
What accounts for the transient nature of the neuromus-
cular phenotype in FGFR2mutants? One possibility is that
expression of FGF7/10/22 by muscles is transient, with
other organizers taking their place later. Indeed, levels of
FGF7, -10, and -22 mRNAs declined during the first post-
natal week and were barely detectable by P21 (Figure 2H).
In addition, anti-FGFR2 immunoreactivity was present at
relatively high levels at synaptic sites in fetal muscle, but
levels declined postnatally (Figure 2I). Loss of staining
following denervation showed that immunoreactivity was
associated with nerve terminals (Figure S3A); its absence
in FGFR2flox/flox; HB9-Cre mice showed that it was spe-
cific (Figure S3B). Thus, developmental regulation of
FGF ligands in muscle and their receptor in motor nerve
terminals provides a partial explanation for the transient
neuromuscular phenotype of FGFR2 mutants.
Laminin b2-Dependent Presynaptic Maturation
at Postnatal NMJs
The transient requirement for FGF signaling implies that
additional factors act subsequently to FGFs to promote
clustering of vesicles at synaptic sites and/or compensate
for the loss of the FGF signaling. b2 laminins (a/b/g heter-
otrimers containing the b2 subunit) are reasonable candi-
dates for such additional factors. Laminins composed of
a2, a4, or a5 plus b2 and g1 subunits are synthesized by
muscle and concentrated in the basal lamina that forms
the synaptic cleft material at the NMJ; extrasynaptic por-
tions of the basal lamina are rich in b1 but poor in b2 lam-
inins (Patton et al., 1997). b2 laminins promote presynaptic
differentiation in vitro (Son et al., 1999; Nishimune et al.,
2004), and mice lacking laminin b2 exhibit defects in pre-
synaptic differentiation that lead to lethality during the
third postnatal week (Noakes et al., 1995; Knight et al.,
2003). Neuromuscular failure in LAMB2/ null miceCell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc. 181
Figure 2. FGF-Dependent Presynaptic Differentiation at the Embryonic NMJ
(A) Schematic representation of the FGFR2b-specific mutant allele. Splicing of exon 7 to exons 8 and 9 generates 2b and 2c variants, respectively.
To specifically inactivate FGFR2b without affecting FGFR2c expression, a stop codon (TGA) was generated in exon 8.
(B) Quantitation of synaptic vesicles failing to correctly aggregate in nerve terminals of E16 and E18 control and FGFR2b/ mutant NMJs. Ratio of
levels of extrasynaptic to synaptic (ExSy/Sy) synaptophysin staining is shown. Bars showmean ±SEM for at least 8 NMJs per condition. *: differs from
age-matched control at p < 0.01 by Student’s t test.
(C–E) Inactivation of FGFR2b diminishes clustering of synaptic vesicles in motor nerve terminals. Whole triangularis sterni muscles (C–D) and dia-
phragm (E) from E18 FGFR2b/ and control embryos were stained with antibodies to synaptophysin (Syn) plus antibodies to neurofilament (NF)
to show axons (C–D) or with BTX to show postsynaptic sites (E). Terminals starred in (C) enlarged in (D). Vesicle restriction to control terminals is strik-
ing by E18, while vesicles are present in distal (arrowheads) but not proximal (arrow) preterminal portions of mutant axons.
(F) Schematic representation of FGFR2flox/flox conditional allele and two transgenic lines, HB9-Cre and Isl-Cre, which express Cre selectively in mo-
toneurons. Cre excises exons 8–10 to inactivate FGFR2.
(G) FGFR2mutant neuromuscular phenotype decreases postnatally. Diaphragms from control and FGFR2flox/flox; HB9-Cre mice were stained for syn-
aptophysin and BTX at the ages indicated. Arrowheads indicate preterminal axons.182 Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc.
Figure 3. Laminin b2-Dependent Presynaptic Maturation at the Postnatal NMJ
(A) Schematic representation of the LAMB2 mutation. A neomycin cassette replaces the second coding exon (exon 3), generating a null allele.
(B) Laminin b2 neuromuscular phenotype appears postnatally. Diaphragms from LAMB2/ and control mice were stained for synaptophysin (green)
and BTX (red) at ages indicated. Levels of synaptophysin are similar at neonatal mutant and control NMJs, but levels in mutants fail to increase during
development as they do in controls.
(C) Quantitation of the percentage of postsynaptic membrane covered by presynaptic terminals in P0, P7, and P14 control and LAMB2/NMJs. Bars
show mean ± SEM for at least 10 NMJs per condition. *: differs from age-matched control at p < 0.01 by Student’s t test.
(D) Persistence of vesicles in preterminal axons (arrowheads) of FGFR2flox/flox; HB9-Cre; and LAMB2/ double mutants (DKO; P14, diaphragms,
stained as in B). In contrast to the DKO, few vesicles are seen in preterminal portions of axons in controls or in either single mutant at this age.
(E) High magnification of DKO demonstrating persistence of vesicles in preterminal axons (arrowheads).
Bars are 3.3 mm in (B), 4 mm in (D), and 1 mm in (E).results from lack of muscle-derived laminin b2, as defects
can be rescued by selective transgenic expression of lam-
inin b2 in muscle (Miner et al., 2006).
To assess the possibility that FGFs and b2 laminins
regulate presynaptic differentiation sequentially, we ex-
amined neonatal laminin b2 null mutants (LAMB2/;
Figure 3A). The size of nerve terminals in diaphragm and
the apparent density of vesicles in terminals did not differ
detectably between LAMB2/ mice and littermate con-
trols during the first few postnatal days (Figure 3B). By
P7, however, mutant NMJs were smaller than those in
controls, the density of vesicles was reduced, and the
fraction of the postsynaptic membrane covered by nerve
terminals was significantly decreased (Figures 3B and
3C). Similarly, the density of active zones in control and
mutant nerve terminals was similar at birth but was signif-
icantly greater in controls than in mutants by the end of thefirst postnatal week (data not shown; Nishimune et al.,
2004). Thus, laminin b2 is required for postnatal but not
prenatal presynaptic differentiation.
To examine whether the presence of laminin b2 ac-
counted for the recovery of the synaptic defects observed
in FGFR2 mutants, we used mutants lacking both pre-
synaptic organizers. If laminin b2 compensates for the
absence of FGFR2, one would expect a more severe neu-
romuscular phenotype in double mutants than in either
single mutant. Vesicles were highly clustered at synaptic
sites in both FGFR2flox/flox; HB9-Cre; and LAMB2/
mice at P14 but were abundant in preterminal portions
of double mutants (Figures 3D and 3E; extrasynaptic/
synaptic ratio, 0.31 ± 0.02 for control, 0.70 ± 0.05 in
double mutant at P14; p < 0.00001). Thus, FGF and lami-
nin b2 signals may functionally compensate for each other
at the NMJ.(H) RT-PCR analysis of leg muscles shows postnatal decline in FGF7, -10, and -22 mRNA levels. Glyceraldehyde 3-phosphate dehydrogenase
(G3PDH) was used as a control.
(I) Immunofluorescence shows FGFR2 associated with motor nerve terminals at BTX-rich synaptic sites. Levels are high at E18 then decline post-
natally (P14 and P28).
Bars are 10 mm in (C–E), 12 mm for (G), and 5 mm in (I).Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc. 183
Identification of Additional Organizing Factors
Presynaptic differentiation proceeds to a considerable ex-
tent at the NMJ in the absence of both FGFR2 and laminin
b2, suggesting that additional organizers exist. To identify
such factors, we used the electric organ of Torpedo cali-
fornica. This tissue is rich in myocyte-related electrocytes,
one side of which is almost completely covered by motor
nerve terminals. Due to the large size of these synapses
and the paucity of contractile proteins, electric organs
serve as an exceptionally rich source of NMJ compo-
nents. Knowing that some synaptic organizing molecules
persist in the adult electrocyte (Nitkin et al., 1987; Sunder-
land et al., 2000), we applied to Torpedo electric-organ
methods previously used to isolate FGF22 from mouse
brain (Umemori et al., 2004).
Briefly, extracts of electric organ were applied to puri-
fied motoneurons in low-density culture, and fractions
were sought that led to clustering of synaptic vesicles in
neurites, as assessed by staining for synapsin. Proteins
that were solubilized at high ionic strength from an extra-
cellular matrix-rich fraction not only promoted vesicle
clustering but also increased both neurite length and neu-
rite branching (Figure 4A). We fractionated the extract
chromatographically, using vesicle clustering as a bio-
assay. Weak anion-exchange chromatography (DEAE) re-
vealed a peak of vesicle-clustering activity eluting at
100 mM NaCl that had no detectable effect on neurite
length or branching (data not shown). Proteins in this ac-
tive fraction were further fractionated by successive steps
of strong anion-exchange chromatography (HiTrap Q), gel
filtration (Superdex 200), and cation-exchange chroma-
tography (MONO-S; Figure 4B; data not shown). The
most active fractions following the MONO-S column
were analyzed by SDS-PAGE. The only visible proteins
appeared as a triplet ranging from22 to 28 kDa (Figure 4C);
neighboring fractions with diminished activity contained
little or none of this triplet.
The three bands were excised separately from gels and
analyzed by tandem mass spectrometry. Peptides in all
three bands contained sequences with glycine at every
third residue (GXY repeats), suggesting that the activema-
terial was collagenous (Table S1). The same collagen-like
sequences were present in all three bands, suggesting
that all contained proteins derived from the same gene
or genes. Because similar GXY repeats are present in
>60 mammalian collagen-like chains and the Torpedo ge-
nome remains unsequenced, we could not match these
Torpedo sequences to particular genes. However, the
28 kDa band contained three noncollagenous sequences
that were highly similar (>90% identity; see Table S1) to
sequences in the noncollagenous carboxy-terminal
(NC1) domains of chick and mammalian collagen a(IV)
chains (Miner and Sanes, 1994; Oohashi et al., 1995). To
verify the identity of the purified material, we used an an-
tibody that recognizes NC1 domains of multiple collagen
a(IV) chains. The antibody reacted with all three bands in
the active fraction, showing that all contained NC1-
derived epitopes (Figure 4D). These results suggest that184 Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc.fragments of Torpedo collagen IV are capable of cluster-
ing vesicles in motor axons.
Presynaptic Organizing Activity of Collagen
a2, a3, and a6(IV) NC1 Domains
The vesicle-clustering proteins we isolated contained epi-
topes derived from both NC1 and collagenous domains.
Recent studies have demonstrated biological activities
in NC1 domains of several collagens (reviewed in Ortega
andWerb, 2002).We therefore askedwhether synaptic or-
ganizing activity resided in the NC1 domain of a collagen
IV chain. The fraction analyzed (which had been purified
on DEAE, Q, and Superdex but not MONO-S columns)
contained several larger bands not seen in the most
pure fractions. These bands also reacted with the anti-
NC1 antibody (Figure 4E), and sequencing showed that
they contained some of the same collagenous and non-
collagenous peptides present in the more pure fractions
as well as additional collagenous sequences (Table S2).
Treatment of this fraction with collagenase, which digests
GXY sequences, led to a loss of all pre-existing bands and
the generation of a predominant 20 kDa NC1-reactive
band plus a weaker 60 kDa band. These bands likely rep-
resent a single NC1 domain and an SDS-resistant multi-
mer, respectively (Borza et al., 2001; Figure 4E). Collage-
nase-treated fractions retained the ability to induce
synapsin aggregation in chick motoneurons (Figure 4F).
These results suggest that the active polypeptides consist
of NC1 domains linked to collagenous sequences of vari-
able lengths and that their ability to cluster synaptic vesi-
cles resides in the NC1 domains.
Mammalian genomes contain six genes that encode
collagen a(IV) chains: COL4A1–COL4A6 (Hudson et al.,
2003). We assessed the effects of all six recombinant
human collagen IV NC1 domains on motoneurons to de-
termine whether NC1 domains were sufficient to cluster
vesicles and which were active. Recombinant a2, a3,
and a6 NC1 domains clustered vesicles, whereas a1,
a4, and a5 NC1 domains were inactive in this assay
(Figure 4G). In light of the finding that collagen IV stabilizes
AChR clusters induced by soluble factors in a myogenic
cell line (Smirnov et al., 2005), we also asked whether
NC1 domains could induce or stabilize AChR clusters
and found that they could not (Figure S4).
Collagen a1/2(IV)-Dependent Presynaptic
Differentiation
Collagen a1/2(IV) are present throughout the basal lamina
in adult muscle fibers, whereas the a3–5 chains are pres-
ent only at synaptic sites (Miner and Sanes, 1994). We
used a panel of chain-specific antibodies to ask when
each chain appeared. The a1/2 chains are present
throughout the embryonic myotube basal lamina and re-
main present in both the synaptic and extrasynaptic basal
lamina throughout life. In contrast, the a3–6 chains are un-
detectable in embryonic basal lamina and do not appear
at synaptic sites until the third postnatal week (Figure 5A;
data not shown).
Figure 4. Collagen IV Is a Presynaptic Organizing Molecule
(A) Cultured motoneurons (MNs) stained with anti-neurofilament (NF) to visualize neurites and synapsin (Syn) to assess the distribution of synaptic
vesicles. Prior to staining, cultures were incubated 48 hr in control medium in the presence of Torpedo electric organ extract, purified active material
from Torpedo (MONO-S column; see B), or human recombinant a6 NC1 domain of collagen IV (5 mg/ml). The crude electric organ extract promoted
neurite elongation and branching as well as synaptic vesicle aggregation. The MONO-S-purified protein and a6 NC1 domain also promoted synaptic
vesicle clustering but had little effect on neurite length or branching. Brackets indicate areas enlarged to demonstrate synapsin staining. Bars
are 25 mm.
(B) Purification of vesicle-clustering material through sequential DEAE, Q (not shown), Superdex, and MONO-S columns. Activity (bars) was assayed
as in (A) and expressed as the number of vesicle aggregates per neuron. Protein concentration was monitored by absorbance at 280 nm (black lines).
Gray line shows NaCl concentration of eluate.
(C) The most active fractions from the MONO-S column were pooled, separated by SDS-PAGE, and stained with Coomassie Colloidal Blue. Bands
indicated with arrowheads were excised for sequencing.
(D) The most active fractions from the Superdex separation were subjected to immunoblotting with an antibody that recognizes the NC1 domain of
multiple collagen a(IV) chains. The three immunoreactive bands at 22–28 kDa (arrowheads) correspond to the major protein components in (C).
(E) Treatment of an active fraction from Superdex separation with 100 or 1000 units of collagenase reduced most of the NC1-positive bands to
20 kDa or 60 kDa.
(F) Collagenase-treatedmaterial retained its vesicle-clustering activity when assayed as in (A) and (B). Control solution contained 1000 U collagenase.
Var indicates vesicle-rich varicosities. The dashed line indicates levels of controls. Bars show mean ± SEM for three independent experiments.
*: differs from controls at p < 0.05 by ANOVA.
(G) Motoneurons were treated for 48 hr with 5 mg/ml recombinant human collagen NC1 domains as in (A). The a2, a3, and a6 NC1 domains induced
vesicle clustering. Var indicates vesicle-rich varicosities. The dashed line indicates levels of controls. Bars show mean ± SEM for five experiments.
*: differs from controls at p < 0.01 by ANOVA.To initiate analysis of collagen IV in vivo, we first focused
on the early-appearing a1/2 chains. Collagen a(IV) chains
are secreted in the form of trimers. Although in principle
the six collagen a(IV) chains could assemble into >50
homo- and heterotrimers, biochemical analysis indicates
that only three combinations exist: (a1)2(a2), (a3)(a4)(a5),
and (a5)2(a6) (Figure 5B; Boutaud et al., 2000; Borza
et al., 2001). In the absence of any single chain, the inabil-ity to assemble the corresponding trimer leads to the ab-
sence of the other chains from the basal lamina (Hudson
et al., 2003). Thus, neither a1 nor a2 chains are present
in basal laminae of COL4A1 mutants. Although null
COL4A1 mutant embryos die before any synapses form
(Poschl et al., 2004), a viable COL4A1 mutant was
recently identified in which a small deletion decreases
trimer assembly by a dominant-negative mechanismCell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc. 185
Figure 5. Collagen IV-Dependent Formation of the NMJ
(A) Collagen a1(IV) and a2(IV) chains are present throughout the myotube’s basal lamina from birth, whereas collagen a3–6(IV) chains appear spe-
cifically at the NMJ during the third postnatal week.
(B) The six collagen a(IV) chains assemble into only three trimers. Gray boxes indicate the N-terminal 7S domain; gray rods indicate the collagenous
domain; and other colors indicate NC1 domains.
(C) Schematic representation of COL4A1Dex40 mutant. A single nucleotide exchange in the splice acceptor site of exon 40 (G to A) causes a deletion of
exon 40, leading to production of a protein that blocks trimer assembly and secretion.
(D) Reduction of collagen a2 (IV) in P3 COL4A1Dex40 mutant muscle. Nidogen 1 (entactin) levels appear unchanged.
(E) Quantification of synaptic vesicles failing to correctly aggregate in nerve terminals of P3 control and COL4A1Dex40 mutant NMJs. Ratio of levels of
extrasynaptic to synaptic synaptotagmin 2 staining (ExSy/Sy) is shown. Bars show mean ± SEM for at least 41 NMJs per condition. *: differs from
age-matched control at p < 0.01 by Student’s t test.
(F) NMJs from COL4A1Dex40 mutant and littermate controls at P3 stained with antibodies to synaptotagmin 2 (Syt) and BTX. Arrowheads indicate pre-
terminal portions of axons. Synaptic vesicles are less restricted to synaptic portions of nerve terminals in mutants.
(G) NMJs from COL4A1Dex40 mutant and littermate controls at P21 stained with antibodies to synaptotagmin 2 (Syt) and BTX. No defects are detect-
able in mutants after the first 3 postnatal weeks.
Bar is 5 mm in (A), (D), (F), and (G).(COL4A1Dex40; Gould et al., 2005, 2006; Figure 5C). We
used COL4A1Dex40/+ mice to assess the role of collagen
a1/2(IV) in nerve terminal formation.
Muscles formed normally in COL4A1Dex40/+ mutants.
Levels of collagen a2(IV) were decreased, but the basal186 Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc.lamina was intact, as shown by normal staining with anti-
bodies to nidogen 1 (Figure 5D). In P3 heterozygotes, the
density of synaptic vesicles was increased in preterminal
portions of motor axons (Figures 5E and 5F), as described
above for FGFR mutants. In addition, sprouts extended
from nerve terminals more frequently in mutants than in
controls (data not shown). However, by the third postnatal
week synaptic phenotypes were no longer observed
(Figure 5G). This recovery suggests that either enough col-
lagen a1/2(IV) eventually accumulates postnatally in the
mutant basal lamina to allow for proper nerve terminal
maturation or that other factors such as laminin b2 or the
collagen a3/6(IV) chains are capable of compensating.
Collagen a3–6(IV)-Dependent Maintenance
of Nerve Terminals
The selective association of the collagen a3–6(IV) chains
with synaptic sites (Figure 5A) taken together with the
known rules of trimer assembly (Figure 5B) implies that
(a3)(a4)(a5) and (a5)2(a6) trimers are present at the NMJ.
To test the role of these chains in NMJ formation in vivo,
we used a set of three targeted mutants: COL4A3/,
COL4A5/Y, and COL4A6/Y (Figure 6A; COL4A5 and
COL4A6 are on the X chromosome). We predicted that
a3 and a4 chains would be absent from the NMJs in
COL4A3/ mutants, that a3–6 chains would be absent
in COL4A5/Y mutants, and that only the a6 chain
would be absent in COL4A6/Y mutants (Figure 6B). We
confirmed these predictions by immunostaining of
COL4A3/, COL4A5/Y, and COL4A6/Y muscle (Fig-
ure S5 and data not shown). Thus COL4A3/ and
COL4A6/Y mutants each lack one of the two synapse-
specific collagen a(IV) chains with vesicle-clustering activ-
ity (a3 and a6), whereas COL4A5/Y mutants lack both of
these chains.
COL4A6/Y mice are healthy, fertile, and display no
known defects (Y. Ninomiya, personal communication).
COL4A3/ and COL4A5/Y appear healthy at birth, but
die at 6-32 weeks of age due to renal defects (Miner and
Sanes, 1996; Cosgrove et al., 1996; Rheault et al., 2004).
NMJs in COL4A3/ or COL4A6/Y muscles, which lack
either the a3 or a6 chain, respectively, did not differ
detectably from those in littermate controls (Figure S6).
Likewise, no nerve-terminal defects were observed in
COL4A5/Y muscle during the first three postnatal weeks,
as expected from the late appearance of the collagen a3–
6(IV) chains (Figures 6C, S7A, and S7B). In 1-month-old
COL4A5/Y diaphragms, however, axons had retracted
from portions of the AChR-rich postsynaptic membrane
(Figure S7C). By 2 months of age, about half of the
NMJs were aberrant (Figures 6D–6G). First, whereas
NMJs in control muscle are composed of branches ar-
ranged in a pretzel-like configuration, pre- and postsynap-
tic specializations are often fragmented in COL4A5/Y
NMJs. Second, whereas nerve terminals completely cov-
ered AChR-rich postsynaptic sites in control NMJs, some
AChR-rich fragments were unapposed by nerve terminals
in 25% of COL4A5/Y NMJs (21/80; arrowheads in
Figure 6D). Third, neurofilaments formed ring-like struc-
tures in nerve terminals at someCOL4A5/Y NMJs (arrows
in Figures 6F and 6G). Similar structures are sometimes
seen in immature control NMJs and resemble microtu-
bule-rich loops recently described in maturing DrosophilaNMJs (Roos et al., 2000). Finally, whereasmotor axons are
cylindrical in controls, the preterminal axon segments
were often distended at COL4A5/Y synaptic sites (arrow-
heads in Figure 6F).
Several observations suggested that these defects
were due to the loss of both collagen a3(IV) and a6(IV)
from synaptic sites in the mutant. First, as noted above,
we detected no defects at NMJs in diaphragms of
COL4A3/ or COL4A6/Y mice, which lack a3 or a6, re-
spectively. Second, loss of the a3–6 chains did not lead
to a general disruption of the basal lamina, as levels of
collagen a1(IV), collagen a2(IV), and laminin b2 appeared
normal at NMJs in COL4A5/Y muscles (Figure S5 and
data not shown). Third, synaptic defects were not second-
ary to the renal defects since lethal renal failure occurs in
both COL4A3/ and COL4A5/Y mutants (Miner and
Sanes, 1996; Rheault et al., 2004), but synaptic defects
were detected only in the latter. Finally, synaptic defects
were not secondary to myopathy since central nuclei
(which mark fibers that have degenerated and regener-
ated) were rarely observed in COL4A5/Y muscles (Fig-
ure S8). Together, these results indicate that the two
synapse-specific collagen IV chains capable of clustering
vesicles in cultured motoneurons also affect NMJ archi-
tecture in vivo and that the a3 and a6 chains have overlap-
ping or redundant functions at the synapse.
DISCUSSION
Over the past decade, several molecules have been iden-
tified that, when applied to cultured neurons, are capable
of promoting at least some steps in the transformation of
neurites into functional nerve terminals. These results led
us to ask what roles molecules with similar in vitro bio-
activities play in vivo. Here, we identified novel synaptic
organizers in vitro then used a set of targeted mouse mu-
tants to ask whether they participate in patterning a single
synapse, the NMJ. Our results, summarized in Figure 7,
lead to three main conclusions. First, at least three sets
of presynaptic organizers (FGFs, b2-laminins, and colla-
gens IV) are required for complete presynaptic differentia-
tion at the NMJ. Second, these organizers act sequentially
to pattern the motor nerve terminal. Third, part of the ex-
planation for the sequential effects of the FGF, laminin,
and collagen signaling systems lies in their distinct devel-
opmental regulation.
Multiple Organizers of Motor Nerve Terminals
FGFs have been implicated in multiple aspects of neural
development but have been little studied in the context
of synaptogenesis. We isolated FGF22 in a search for
brain-derived proteins capable of promoting presynaptic
differentiation in cultured neurons and then found that its
closest relatives, FGF7 and -10, shared this bioactivity
(Umemori et al., 2004). FGF22 is synthesized by cerebellar
granule cells and promotes differentiation of their main
synaptic inputs, mossy fibers, in vivo. Because FGF7,
-10, and -22 are all expressed by developing muscle, weCell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc. 187
Figure 6. Collagen IV-Dependent Maintenance of the NMJ
(A) Schematic representation of COL4A3, COL4A5, and COL4A6 mutants. For COL4A3/ mutants, the first three exons in the NC1 domain were
replaced with a neo cassette. For COL4A5/Y mutants, a point mutation converting a glycine to a STOP was inserted in exon 1. For COL4A6/Y mu-
tants, parts of exon 2 and intron 2 were replaced with a neo cassette. All three mutants are functional nulls.
(B) Collagen a(IV) chain content of synaptic cleft at the NMJ in wild-type andmutant mice, as predicted by protomer composition (B) and confirmed by
immunofluorescence (Figure S4).
(C) NMJs from COL4A5/Y and littermate controls at P21 stained with antibodies to synaptotagmin 2 (Syt) plus BTX. No defects are detectable in
mutants during the first 3 postnatal weeks.
(D) NMJs from P56 COL4A5/Y and littermate control diaphragm, stained with antibodies to synaptotagmin 2 (Syt) and BTX. Receptors are frag-
mented rather than branched in mutants, and some AChR-rich patches (arrowheads) are unapposed by presynaptic boutons.
(E) Number of discrete AChR fragments per NMJ in COL4A5/Y and control muscles (n = 100 in mutant and 80 in controls NMJs).
(F) NMJs from P56 COL4A5/Y and littermate control diaphragm stained with antibodies to neurofilaments (NF) plus BTX. Portions of preterminal
axons are distended in mutants (arrowheads), and neurofilaments terminate in whorls in some mutant terminals (arrows). Brackets indicate areas
enlarged in (G).
(G) Higher magnification of neurofilament in controls andCOL4A5/Y NMJs. Arrows highlight neurofilaments terminating in whorls inmutant terminals.
Bar is 5 mm in (C), (D), (F), and (G).used isoform-specific and conditional alleles of their com-
mon receptor, FGFR2, to probe their role. Results from
FGFR2b/ mice are subject to the caveat that the muta-
tion affects all cells, and results from FGFR2flox/flox mice188 Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc.are subject to the caveat that both FGFR2 isoforms were
deleted, but the congruence of results from the two alleles
gives us confidence that FGF7/10/22 signaling to motor
axons is required for complete presynaptic differentiation.
In fact, we may have underestimated their role in that
members of this subfamily activate FGFR1b to aminor ex-
tent under some circumstances (Zhang et al., 2006).
A second organizer, laminin b2, was initially identified as
a component of the synaptic cleft at the NMJ. In vitro and
in vivo studies demonstrated a role for muscle-derived b2
laminins in the differentiation of motor nerve terminals
(Hunter et al., 1989; Noakes et al., 1995; Son et al.,
1999; Knight et al., 2003; Miner et al., 2006). Integrins
and dystroglycan are the predominant cell-surface recep-
tors for laminins in many cell types, but at the NMJ laminin
b2 appears to act by binding to and clustering voltage-
sensitive calcium channels, which then recruit and
stabilize other components of the release apparatus
(Nishimune et al., 2004).
The third organizers, the collagen IV chains, have not
hitherto been implicated in synaptogenesis. Recently,
the NC1 domains of basement membrane collagens IV,
XV, and XVIII have been found to possess a variety of bio-
activities in vitro, including modulation of angiogenesis
and adhesion (reviewed in Ortega and Werb, 2002). Evi-
dence for roles in neural development includes the dem-
onstration that the NC1 domain of collagen IV promotes
Figure 7. Sequential Effects and Expression of Multiple Pre-
synaptic Organizers
(A) Neuromuscular expression of FGF7/10/22, b2 laminins, and colla-
gen IV chains along with defects resulting from their loss.
(B) Model of sequential synaptic organizers. FGFs of the 7/10/22 sub-
family act through FGFR2b to cluster synaptic vesicles in embryos.
Collagen a2(IV) also promotes clustering at early stages. b2 laminins
act through calcium channels to promote postnatal maturation of
nerve terminals. Collagens a3 and a6 (IV) are required for synaptic
maintenance in adults.neurite outgrowth from cultured rodent sympathetic
neurons (Lein et al., 1991) and that the NC1 domain of col-
lagen XVIII regulates axon guidance in C. elegans and ze-
brafish (Ackley et al., 2001; Schneider and Granato, 2006).
Our results suggest that collagen IV chains play two dis-
tinct roles in vivo. During early development, the collagen
a2(IV) chains are necessary for the proper differentiation of
motor nerve terminals. These collagen IV chains might
compensate for the absence of FGF signaling and laminin
b2 in mutants lacking both organizers (Figure 4). After
nerve terminals have matured, the synapse-specific colla-
gen a3 and a6(IV) chains are necessary to maintain termi-
nals. Although postsynaptic fragmentation is observed in
mature COL4A5/Y NMJs, we believe that collagen IV af-
fects nerve terminals directly because no postsynaptic
defects were evident in neonatal COL4A1Dex40/+ mice,
and presynaptic defects predominate in 1-month-old
COL4A5/Y mice.
Interestingly, whereas loss of other presynaptic orga-
nizers led to synaptic defects in most muscles, loss of
collagens a3–6(IV) predominantly affected the diaphragm
(data not shown). One possible explanation for this selec-
tivity is that it results from intermuscular differences in the
relative levels of the a1/2 versus the a3–6(IV) chains. It is
worth noting that marked intermuscular differences in
phenotype have been observed in mutants lacking an-
other synaptic organizer, agrin (Pun et al., 2002).
Sequential Effects of Presynaptic Organizers
Genetic analysis demonstrated that FGFs, laminins, and
collagens IV act sequentially at a single synapse: FGF7/
10/22andcollagena1/2(IV) inembryonic synapses,b2 lam-
inins in early postnatal synapses, and collagens a3–6(IV)
in mature synapses. Thus, one answer to a question that
motivated this work—why so many organizers?—is that
they act sequentially to pattern the NMJ by separately
affecting its formation, maturation, and maintenance.
What determines the sequence in which FGFs, b2 lam-
inins, and collagens IV act? One factor is their patterns of
expression. Levels of FGF7, -10 and -22 mRNA in myo-
tubes and of FGFR2 in nerve terminals decline dramati-
cally shortly after birth, whereas, a3(IV) and a6(IV) chains
of collagen IV become abundant only after the second
postnatal week. Developmental regulation of laminin b2
and collagen a2(IV), in contrast, does not readily explain
the timing of their effects: both are present in the synaptic
cleft from prenatal stages into adulthood. Interestingly,
however, the P/Q-type calcium channel (Cav2.1) replaces
its homolog, the N-type channel (Cav2.2), in motor nerve
terminals during the first postnatal week (Urbano et al.,
2002). Since laminin b2 binds to and signals through cal-
cium channels, it will be interesting to test whether it differ-
entially binds to or signals through Cav2.1 and Cav2.2.
Likewise, collagen a3–6(IV) may render the a2(IV) chain re-
dundant postnatally.
Although we have focused on the temporal differences
among organizers, it is also possible that each affects the
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structures. Differentiation of the nerve terminal involves
multiple steps, including formation of active zones, clus-
tering of vesicles, recruitment of calcium channels, acqui-
sition of release capabilities, aggregation of mitochondria,
and so on. Triggering any of these steps may lead to
assembly of a nerve terminal in vitro, but each might be
regulated separately in vivo. Indeed, each presynaptic or-
ganizer appears to have a different receptor on the motor
nerve terminal. Thus, each target-derived organizer may
have a different primary effect on a different aspect of
presynaptic assembly.
How Many Organizers?
Each of the organizers we have studied is part of a group.
Three FGFs (FGF7, FGF10, and FGF22) that signal
through FGFR2b and promote vesicle clustering in vitro
are expressed by myotubes. Three laminin heterotrimers
containing the b2 subunit (a2b2g1, a4b2g1, and a5b2g1)
are assembled by muscle and are present in the synaptic
cleft at the NMJ (Patton et al., 1997). Three collagen a(IV)
chains capable of promoting vesicle clustering in vitro (a2,
a3, and a6) are also present in the synaptic cleft. Thus, the
potential exists for complex and subtle regulation of
presynaptic differentiation.
However, even more presynaptic organizers may be in-
volved in patterning the NMJ. Even in the absence of both
laminin b2 and FGFR2, considerable presynaptic differen-
tiation occurs at sites of nerve-muscle contact, and ani-
mals are viable for at least 2 postnatal weeks. As noted
above, these additional factors might include FGFs signal-
ing through FGFR1b and collagen a2(IV). Additional candi-
dates include signals that have been shown to act on
central neurons, such as SynCAM, eph kinases/ephrins,
neuroligin/neurexin, and Wnts (see Introduction). Studies
of Wnts in Drosophila (Packard et al., 2002) and of ephrins
(Feng et al., 2000) and neurexins (Sons et al., 2006) in
mouse are consistent with—but do not, so far, provide
direct evidence for—this idea. Alternatively, additional or-
ganizers may remain to be discovered. Indeed, FGFs and
collagen IV account for only part of the presynaptic orga-
nizing activity we have detected in brain (Umemori et al.,
2004) and Torpedo (this study), respectively.
EXPERIMENTAL PROCEDURES
Cell Culture
Motoneurons were purified from E5.5 chick embryos and cultured as
previously described (Henderson et al., 1996; Umemori et al., 2004).
Torpedo extracts were added to cultures 4–8 hr after plating. Human
recombinant collagen IV NC1 domains were prepared as previously
described (Petitclerc et al., 2000) and added to cultures >5 hr after
plating. After 48 hr in culture, motoneurons were fixed and stained
with anti-synapsin, and vesicle-rich puncta were counted on an epi-
fluorescence microscope (Zeiss). For RT-PCR, total RNA was pre-
pared from cultured cells using an RNA purification kit (Stratagene).
C2 cells (ATCC, Manassas, VA) were cultured as previously
described by Kummer et al. (2004). For studies of AChR clustering,
recombinant NC1 domains (5 mg/ml) and/or agrin (1 mM) were added
with fusion medium. For cocultures, C2 myoblasts were plated in
8-well Lab-Tek Permanox chamber slides, grown until confluent, and190 Cell 129, 179–193, April 6, 2007 ª2007 Elsevier Inc.fused in medium containing 2% horse serum. Two days later, 2000
motoneurons per well were added and maintained in motoneuron
medium. FGFR2bAP or FGFR2cAP were prepared as described by
Umemori et al. (2004) and added with motoneurons. Three days later,
cultures were fixed and stained as described below.
Animals
A naturally occurring COL4A1 mutant in which the fortieth exon is
deleted was described previously (COL4A1Dex40; Gould et al., 2005,
2006). Two copies of COL4A1Dex40 act as a functional null, thereby ter-
minating embryogenesis before any synapses form. However, a single
copy of COL4A1Dex40 reduces the amount of collagen secreted and
assembled into the basal lamina. The COL4A1Dex40 mutation was
backcrossed into two different strains (15 generations onto C57/B6
and 5 generations onto BALB/C); the synaptic phenotype at P3 was
observed in both genotypes. Targeted null mutants of the collagen
a3(IV) gene (COL4A3/; Miner and Sanes, 1996), the collagen a5(IV)
gene (COL4A5/Y; Rheault et al., 2004, and the laminin b2 gene
(LAMB2/; Noakes et al., 1995) were described previously. All have
been shown to be functional nulls. Two alleles of the FGFR2 gene
were also described previously: a conditional allele in which Cre-medi-
ated excision leads to a functional null (FGFR2flox/flox; Yu et al., 2003)
and one in which a nonsense mutation in the unique exon of the
FGFR2b isoform leads to generation of a truncated nonfunctional pro-
tein without affecting expression of FGFR2c (FGFR2b/; Eswaraku-
mar et al., 2002). A neomyocin resistance cassette flanked by loxP
sites was present in the FGFR2b- and COL4A5-targeting vectors,
but in both cases they were removed by Cre-mediated recombination
before generating the mice used here. Transgenic mice in which ex-
pression of YFP is dependent on Cre-mediated excision (Thy1-Stop-
YFP; Buffelli et al., 2003) were generated in our laboratory and are
now available from Jackson Laboratories (Bar Harbor, ME). Trans-
genic mice in which Cre recombinase is expressed under control of
regulatory elements from the HB9 gene (HB9-Cre) or the Islet1 gene
(Isl-Cre; Srinivas et al., 2001) were used. To generate HB9-Cre mice,
a previously characterized 10 kb genomic fragment (Lee et al., 2004)
was placed upstream of a cassette containing a Cre cDNA and a poly-
adenylation signal from SV40; the insert was linearized, purified, and
injected into pronuclei by standard techniques. All mutant and trans-
genic mice weremaintained on a C57B6 background, and phenotypes
of mutants were compared to those of littermate controls.
To generate a null mutant of the collagen a6(IV) gene (COL4A6/Y)
parts of exon 2 and intron 2 were replaced with a neomycin resistance
cassette. The mutated exon 2 lacked the signal peptide. Homologous
recombinants were identified by Southern blot analysis using a 300 bp
EcoRI-PstI external probe. Correctly targeted ES cells were injected
into blastocysts to generate chimeras. Male chimeras were used to
establish 129Sv inbred lines.
Histology
Whole mounts and cryostat sections of muscles were fixed and
stained as described by Misgeld et al. (2002). For collagen staining,
sections were fixed for 10 min in ice-cold acetone, treated with a 1:1
mixture of 0.1 M KCl and 0.1 N HCl, then washed in PBS. Mutant
and control tissues were processed together, and images were
acquired with identical settings on a CCD camera (Photometrics)
and analyzed with Metamorph imaging software (Universal Imaging).
Sources of antibodies were as follows: anti-neurofilament, Covance
Research Products (Denver, PA); anti-synaptophysin, Invitrogen
(Carlsbad, CA); anti-FGFR2, Santa Cruz (Santa Cruz, CA) and Abcam
Inc. (Cambridge, MA); anti-acetylated tubulin, Sigma (St. Louis, MO);
anti-SV2, Developmental Studies Hybridoma Bank (University of
Iowa; Iowa City, IA); anti-synaptotagmin 2 (znp-1), Zebrafish Interna-
tional Resource Center (Eugene, OR); and anti-entactin (nidogen-1),
Chemicon (Temecula, CA). Rat monoclonal antibodies to collagen
a1–6(IV) were described previously (Ninomiya et al., 1995). Anti-synap-
sin was a gift from P. Greengard and A. Nairn (Rockefeller University),
and anti-laminin b2 was a gift from R. Timpl (Max Planck Institute, Mu-
nich). A rat monoclonal antibody to several collagen IV NC1 domains
will be described elsewhere (D.B. Borza, personal communication).
Purification of Synaptic Organizing Molecules
Electric organs from Torpedo californicawere homogenized in 400mM
NaCl, 1 mM EDTA, and 1 mM EGTA in 10 mM Tris (pH 7.5) containing
0.1 mg/ml PMSF (TP), then spun at 17,700 g for 30 min. The pellet and
loosely associated fibrous layer were homogenized in 150 mM NaCl,
1 mM EDTA, and 1 mM EGTA in TP, then spun at 17,700 g for
30 min. Salts were removed by homogenizing the pelleted material in
TP. After centrifugation at 17,700 g for 30 min, loosely associated
fibrous material was removed from the pellet by resuspending and
stirring in TP with 3% (w/v) TritonX100 for 30 min. After centrifugation
at 30,100 g, the pellet was again resuspended and stirred in TP with
3% TritonX100 for 30 min. Insoluble material was pelleted by centrifu-
gation; washed with TP; homogenized in 0.2 M sodium bicarbonate
(pH 9.0), 5% glycerol, 1MNaCl, and 0.1mg/ml PMSF (SB); then stirred
overnight. Subsequently, SB containing insoluble material underwent
six cycles of sonication (10 min), homogenization (10 min), and stirring
(30 min) then was centrifuged at 30,100 g for 30 min. The supernatant
was dialyzed against 10 mM Tris (pH 8.0) and 25 mM NaCl (buffer A),
applied to a DEAE-Sepharose FF column, and eluted with a 0–300 mM
linear NaCl gradient in buffer A (AKTAprime FPLC System; Pharmacia).
Active fractions were pooled, dialyzed against buffer A, applied to a
20 ml HiTrap Q column, and eluted with a 0–500 mM linear NaCl gra-
dient. Active fractions were pooled again, concentrated to 500 ml by
centrifugal filtration (Amicon Ultra, Millipore), applied to a Superdex-
200 HR10/30 gel filtration column, and separated in buffer A with
150 mM NaCl. Active fractions were pooled, dialyzed against 20 mM
sodium acetate buffer (pH 5.0), applied to a MONO-S HR 5/5 column,
and eluted with a 0–500 mM NaCl linear gradient. All steps were per-
formed at 4C. Concentrated active fractions were separated on a
4%–20%gradient SDS-polyacrylamide Ready-Gel (BioRad; Hercules,
CA) and stained with Colloidal Coomassie Blue (Invitrogen). Bands
were excised for mass spectrometric analysis at the Harvard Uni-
versity Microchemistry & Proteomics Analysis Facility. For removal of
collagenous sequences, active fractions were incubated with 100 or
1000 Units of ultrapure collagenase (Sigma, St.Louis, MO) for 4 hr at
37C.
Supplemental Data
Supplemental Data include eight figures and two tables and can be
found with this article online at http://www.cell.com/cgi/content/129/
1/179/DC1/.
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